New steps on an old path: Novel estrogen receptor inhibitors in breast cancerMartina Pagliuca, Mario Giuliano, Anna Orsola Maria Russo et al.|Critical Reviews in Oncology/Hematology|2022Cited by 23
Survival Following CDK4/6 Inhibitor Therapy for Hormone Receptor–Positive, <i>ERBB2</i>–Negative Metastatic Breast CancerPier Paolo Maria Berton Giachetti, Carmen Criscitiello, Stefania Morganti et al.|JAMA Network Open|2025Cited by 11